Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
详细信息 查看全文
- 作者：Kuo-Chih Tseng ; Chih-Wei Tseng ; Tsai-Yuan Hsieh ; Cheng-Yuan Peng ; Chih-Lin Lin ; Tung-Hung Su ; Tai-Chung Tseng ; Hans Hsienhong Lin ; Chia-Chi Wang and Jia-Horng Kao
- 刊名：Hepatology Research
- 出版年：2016
- 出版时间：June 2016
- 年：2016
- 卷：46
- 期：7
- 页码：642-649
- 全文大小：389K
- ISSN：1872-034X
文摘
The efficacy of entecavir (ETV) in treatment-experienced chronic hepatitis B (CHB) patients remains unclear. We evaluated the therapeutic responses and virological breakthrough following ETV treatment in hepatitis B e-antigen (HBeAg) positive CHB patients with prior exposure to interferon or nucleoside/nucleotide analog and treatment-naive patients.